Immediate Impact

1 by Nobel laureates 3 from Science/Nature 98 standout
Sub-graph 1 of 18

Citing Papers

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
2021 Standout
2 intermediate papers

Works of Guozhang Liu being referenced

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients
2005
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
1998

Author Peers

Author Last Decade Papers Cites
Guozhang Liu 844 349 99 181 38 1.1k
Roberto Pisoni 583 272 149 161 31 1.1k
Yoshio Konishi 403 321 138 147 55 1.0k
Giorgio Baldari 787 261 221 267 46 1.3k
C Iovine 265 390 62 210 30 885
G Ginocchio 679 518 40 95 36 1.1k
H Schumacher 634 269 94 70 20 1.1k
Harikrishna Makani 782 294 181 88 20 1.2k
Giulia Dell’Omo 708 203 170 78 47 1.3k
Peter de Leeuw 687 216 269 197 42 1.4k
Juan García‐Puig 528 293 85 89 44 1.0k

All Works

Loading papers...

Rankless by CCL
2026